Gut restricted-7
CAS No. 2553218-46-3
Gut restricted-7( GR-7 )
Catalog No. M26241 CAS No. 2553218-46-3
Gut restricted-7 (GR-7) is a covalent and orally active pan-bile salt hydrolase (BSH) inhibitor. It decreases gut bacterial BSHs and decreases deconjugated bile acid levels in the feces of mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 299 | Get Quote |
|
| 10MG | 479 | Get Quote |
|
| 25MG | 777 | Get Quote |
|
| 50MG | 1071 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGut restricted-7
-
NoteResearch use only, not for human use.
-
Brief DescriptionGut restricted-7 (GR-7) is a covalent and orally active pan-bile salt hydrolase (BSH) inhibitor. It decreases gut bacterial BSHs and decreases deconjugated bile acid levels in the feces of mice.
-
DescriptionGut restricted-7 (GR-7) is a covalent and orally active pan-bile salt hydrolase (BSH) inhibitor. It decreases gut bacterial BSHs and decreases deconjugated bile acid levels in the feces of mice.(In Vitro):Gut restricted-7 (60 μM) does not affect the epithelial barrier integrity of Caco-2 cells, suggesting that this compound is relatively nontoxic.?Gut restricted-7 also does not affect microbial biomass.(In Vivo):The C57BL/6 mice fed with either powdered chow containing 0.09% Gut restricted-7 (w/w) for 1 d day or powdered chow alone.?Gut restricted-7 significant inhibits the BSH activity in the feces of inhibitor-treated mice 8 h post-diet change.?20picomol/mg wet mass (~20 μM) of Gut restricted-7 in cecal contents is detected.
-
In Vitro——
-
In Vivo——
-
SynonymsGR-7
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorCDK1| CDK2| CDK3| CDK5
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2553218-46-3
-
Formula Weight510.63
-
Molecular FormulaC25H40FNaO6S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (489.59 mM)
-
SMILESO=C(CF)CC[C@@H](C)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](OS(=O)(O[Na])=O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.McMillin DW, Delmore J, Negri J et al. Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications. Br J Haematol. 2011 Feb;152(4):420-32.
molnova catalog
related products
-
XE 991 dihydrochlori...
A potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively.
-
Kv2-IN-A1
Kv2-IN-A1 is an inhibitor of Kv2.1 and Kv2.2.
-
Indapamide
Indapamide is a non-thiazide sulphonamide diuretic compound, generally used in the treatment of hypertension, as well as decompensated cardiac failure.
Cart
sales@molnova.com